• Fast Track Initiative’s portfolio company Neusignal Therapeutics was named to Forbes Asia’s “100 to Watch 2026” list.
• The list selected 100 startups across 16 Asia-Pacific markets; Japan accounted for nine companies.
• Neusignal, a Tohoku University spinout founded in April 2022, is developing an Alzheimer’s disease drug candidate.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Fast Track Initiative Inc published the original content used to generate this news brief on August 26, 2026, and is solely responsible for the information contained therein.